KR19980034292A - Skin whitening composition containing galloylquinic acid - Google Patents
Skin whitening composition containing galloylquinic acid Download PDFInfo
- Publication number
- KR19980034292A KR19980034292A KR1019960052295A KR19960052295A KR19980034292A KR 19980034292 A KR19980034292 A KR 19980034292A KR 1019960052295 A KR1019960052295 A KR 1019960052295A KR 19960052295 A KR19960052295 A KR 19960052295A KR 19980034292 A KR19980034292 A KR 19980034292A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- skin whitening
- galloyl
- composition
- quinic acid
- Prior art date
Links
Abstract
본 발명은 기미나 주근깨 개선 및 피부 미백제로서 갈로일퀴닉산(galloyl quinic acid)을 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a skin whitening composition containing galloyl quinic acid as an anti-fog and freckles improving and skin whitening agent.
Description
[발명의 명칭][Name of invention]
갈로일퀴닉산을 함유하는 피부 미백용 조성물Skin whitening composition containing galloylquinic acid
[발명의 상세한 설명]Detailed description of the invention
[발명의 목적][Purpose of invention]
본 발명은 기미나 주근깨 개선 및 피부 미백제로서 갈로일퀴닉산 (galloyl quinic acid)을 함유하는 피부 미백용 조성물에 관한 것이다.The present invention relates to a skin whitening composition containing galloyl quinic acid as an anti-finite freckles and skin whitening agent.
[발명이 속하는 기술분야 및 그 분야의 종래기술][Technical Field to which the Invention belongs and Prior Art in the Field]
희고 고운 피부를 갖고자 하는 것은 모든 사람의 한결같은 소망이다. 사람의 피부색은 피부내 멜라닌(melanin)의 농도와 분포에 따라 유전적으로 결정되나, 태양 자외선이나 피로, 스트레스 같은 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 아미노산의 일종인 타이로신(tyrosine)에 타이로시네이즈(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 타이로시네이즈가 멜라닌 합성과정에서 이렇듯 중요한 역할을 하기에 종래 하이드로퀴논이나 아스콜빈산, 코지산(kojic acid), 글루타치온 같은 타이로시네이즈에 저해 활성을 갖는 물질을 연고나 화장료에 배합함으로써, 피부미백이나 기미, 주근깨 개선의 목적에 사용되어 왔으나, 피부에 자극성을 유발하거나 제품 안정성이 좋지 못하여 사용이 제한되고, 또 그 효과도 미약한 단점이 있다.It is everyone's constant desire to have white, fair skin. Human skin color is genetically determined by the concentration and distribution of melanin in the skin, but is also influenced by environmental or physiological conditions such as solar ultraviolet light, fatigue and stress. Melanin is a type of amino acid tyrosine (tyrosine) enzyme called tyrosinase (tyrosinase) acts to convert to dopa (DOPA), dopaquinone (dopaquinone) is produced through a non-enzymatic oxidation reaction. Because tyrosinase plays such an important role in melanin synthesis process, by combining substances having inhibitory activity against tyrosinase, such as hydroquinone, ascolic acid, kojic acid, and glutathione, in ointments or cosmetics, Although it has been used for the purpose of skin whitening, blemishes, and freckles, the use is limited because it causes irritation to skin or poor product stability, and the effect is also weak.
[발명이 이루고자 하는 기술적 과제][Technical problem to be achieved]
본 발명자들은 이러한 문제점들을 해결하고 보다 우수한 미백물질을 개발하고자 수많은 연구와 실험을 거듭한 결과, 이미 그 안전성이 입증되어 있는 천연물들 중에서 미백 효과가 우수한 물질을 탐색하던 중 천연물로부터 분리한 갈로일퀴닉산이 우수한 타이로시네이즈의 저해작용을 나타낼 뿐만 아니라 배양된 세포를 이용한 멜라닌 생성억제 실험과 사람에 대한 실험에서 그 효과가 있음을 밝혀내고 본 발명을 완성하게 되었다.The present inventors have conducted numerous studies and experiments to solve these problems and to develop better whitening materials, and the galloylquine isolated from natural products while searching for a material having excellent whitening effect among natural products that have already been proved in safety. As well as showing an excellent inhibitory effect of tyrosinase on acid, the present invention was found to be effective in melanin production inhibition experiments and human experiments using cultured cells.
[발명의 구성 및 작용][Configuration and Function of Invention]
본 발명은 갈로일퀴닉산(galloyl quinic acid)를 건조중량에 대하여 0.001 내지 20 중량% 함유함을 특징으로 하는 피부미백용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening, characterized in that it contains 0.001 to 20% by weight of galloyl quinic acid with respect to dry weight.
본 발명의 피부미백용 조성물에서 갈로일퀴닉산은 3-o-갈로일-퀴닉산, 4-o-갈로일-퀴닉산, 5-o-갈로일-퀴닉산, 3,5-디-o-갈로일-퀴닉산, 3,4-디-o-갈로일퀴닉산 및 4,5-디-o-갈로일퀴닉산 중에서 선택된 1종 또는 2종 이상을 사용한다.In the composition for skin whitening of the present invention, the galloylquinic acid is 3-o-galloyl-quinic acid, 4-o-galloyl-quinic acid, 5-o-galloyl-quinic acid, 3,5-di-o- One or two or more selected from galloyl-quinic acid, 3,4-di-o-galloylquinic acid and 4,5-di-o-galloylquinic acid are used.
본 발명에 따르면, 갈로일퀴닉산을 건조중량에 대하여 0.001-20 중량%, 바람직하게는 0.01-10 중량%를 피부외용연고나 화장료에 첨가한다. 갈로일퀴닉산을 0.001 중량% 이하 사용하는 경우에는 충분한 미백효과를 기대하기 어렵고, 20 중량% 이상 사용하는 경우에는 제형상 및 제품 안정성에 영향을 미치며 과량 사용에 따른 더이상의 효과증가를 기대할 수도 없고 또한 경제적이지 못하다.According to the present invention, galloylquinic acid is added in an amount of 0.001-20% by weight, preferably 0.01-10% by weight, to the skin external ointment or cosmetics. When galloylquinic acid is used at 0.001% by weight or less, it is difficult to expect sufficient whitening effect.When it is used at 20% by weight or more, it affects the formulation and product stability, and it is impossible to expect further increase in effect due to excessive use. Not economical
본 발명의 피부미백용 조성물은 상기한 갈로일퀴닉산외에도 통상적인 화장료성분으로서 유화제, 가용화제, 오일, 왁스, 지방산, 알콜류, 폴리머, 보습제, 피부보호제, 점증제, 피막형성제, 산화방지제, 금속이온봉쇄제, 자외선차단제, 변색방지제, 비타민류, 수렴제, 방부제, 향료, 색소 등을 화장료의 용도 및 성상 등에 따라 매우 다양하게 사용될 수 있다.The skin whitening composition of the present invention is a common cosmetic ingredient in addition to the galloylquinic acid, as emulsifiers, solubilizers, oils, waxes, fatty acids, alcohols, polymers, humectants, skin protectants, thickeners, film forming agents, antioxidants, metals. Ion blockers, sunscreens, discoloration inhibitors, vitamins, astringents, preservatives, fragrances, pigments and the like can be used in a wide variety of applications and properties of the cosmetic.
본 발명에 따른 피부미백용 조성물은 피부외용 연고나 화장료로서 사용하면 매우 효과적인 것으로 나타났다. 여기서 화장료는 유연화장수, 영양화장수, 영양크림, 맛사지크림, 엣센스, 팩 등을 포함한다.Skin whitening composition according to the present invention was found to be very effective when used as an external skin ointment or cosmetic. Here, the cosmetics include softening cream, nutrient cream, nourishing cream, massage cream, essence, pack and the like.
이하, 본 발명을 실험예 및 실시예에 의거하여 더욱 상세히 설명하고자 한다. 그러나 본 발명의 기술적 범위가 이들로 국한되는 것으로 이해해서는 안된다.Hereinafter, the present invention will be described in more detail based on Experimental Examples and Examples. However, it should not be understood that the technical scope of the present invention is limited thereto.
[제조예][Production example]
갈로일 퀴닉산의 분리Isolation of Galloyl Quinic Acid
신선한 택칠(Euphorbia Helioscopia L.) 전초(全草) 48.5kg을 잘게 절단하여 80% 아세톤 수용액 50ℓ에 담그어 상온에서 10일간 추출한다. 이 추출물을 감압 농축기로 농축한 다음 거름종이(Whatman No. 1)로 걸러 침전을 제거하고 감압건조하여 악 840g의 추출물을 얻었다. 이것을 sephadex LH-20 칼럼 크로마토그라피를 이용(H2O-MeOH→H2O-아세톤)하여 360mg의 3-o-갈로일-퀴닉산를 분리하였다.48.5 kg of fresh Echohorbia Helioscopia L. starch is finely chopped and soaked in 50 L of 80% acetone solution and extracted at room temperature for 10 days. The extract was concentrated with a vacuum concentrator, filtered through a filter paper (Whatman No. 1) to remove the precipitate, and dried under reduced pressure to obtain 840 g of the extract. 360 mg of 3-o-galloyl-quinic acid was isolated using sephadex LH-20 column chromatography (H 2 O-MeOH → H 2 O-acetone).
[실험예 1]Experimental Example 1
상기 제조예에서 분리한 갈로일퀴닉산에 대하여 타이로시네이즈 저해효과를 다음과 같이 측정하였다.The tyrosinase inhibitory effect on the galloyl quinic acid isolated in the preparation example was measured as follows.
효소 타이로시네이즈는 버섯류(mushroom)로 부터 추출한 것으로, 시그마(Sigma)사의 것을 사용하였다. 먼저, 기질인 티로신을 1.5mM의 농도로 소디움 포스페이트 완충액(0.05mol 농도, pH 6.8)에 용액을 만들어 0.3㎖ 분광 광도계 큐벧(Cuvette)에 0.1㎖를 넣고 코팩터(cofactor)인 도파를 0.6mM의 농도로 만들어 0.01㎖씩 첨가한다. 여기에 갈로일퀴닉산을 각각 다른 농도로 첨가하고 각각에 첨가된 갈로일퀴닉산의 부피가 0.1㎖가 되도록 소디움 포스페이트 완충액을 첨가한다. 여기에 타이로시네이즈를 소디움 포스페이트 완충액에 60U/㎖로 제조하여 0.1㎖씩 첨가하여 반응을 진행시킨다. 이때 대조군(Blank)은 타이로시네이즈 대신 완충액만을 0.1㎖씩 첨가한다.Enzyme tyrosinase was extracted from the mushroom (mushroom), Sigma (Sigma) was used. First, a solution of tyrosine, a substrate, was dissolved in sodium phosphate buffer (0.05 mol, pH 6.8) in a concentration of 1.5 mM, and 0.1 ml of 0.3 ml spectrophotometer Cuvette was added, and a cofactor of waveguide was 0.6 mM. Make a concentration and add 0.01 ml each. To each is added galloylquinic acid at different concentrations, and sodium phosphate buffer is added so that the volume of galloylquinic acid added to each is 0.1 ml. Here, tyrosinase is prepared in sodium phosphate buffer at 60 U / ml, and 0.1 ml of each is added to proceed with the reaction. At this time, the control group (Blank) is added only 0.1ml of buffer instead of tyrosinase.
반응은 분광광도계(Spectrophotometer, Beckman DU-7500)를 이용 37℃에서 진행시키며, 1분마다 475 나노미터에서의 흡광도의 변화를 5분간 측정한다. 여기서 얻어진 반응속도(시간에 따른 흡광도의 변화율, dA/dmim)의 차이로 타이로시네이즈의 저해율을 다음과 같은 식으로 구하였다.The reaction was carried out at 37 ° C. using a spectrophotometer (Beckman DU-7500), and the change in absorbance at 475 nanometers was measured for 5 minutes every minute. The inhibition rate of tyrosinase was determined by the difference of the reaction rate (rate of change in absorbance with time, dA / dmim) obtained as follows.
상기 저해율이 50%가 될 때의 갈로일 시키믹산의 농도를 IC50(억제농도 50)으로 표현하였으며, 각각의 갈로일 퀴닉산에 대한 IC50 값은 하기 표 1 에 나타내었다.The concentration of galloyl simic acid when the inhibition rate is 50% was expressed as IC 50 (inhibition concentration 50), and the IC 50 values for each galloyl quinic acid are shown in Table 1 below.
[표 1]TABLE 1
갈로일 퀴닉산들의 타이로시네이즈 저해효과(IC50)Tyrosinase Inhibitory Effect of Galoyl Quinic Acids (IC50)
상기 표 1 의 결과로부터 갈로일 퀴닉산은 타이로시네이즈에 대한 저해효과가 우수함을 알 수 있다.From the results of Table 1, it can be seen that galloyl quinic acid has an excellent inhibitory effect on tyrosinase.
[실험예 2]Experimental Example 2
상기 제조예에서 분리한 갈로일 퀴닉산을 가지고 쥐의 멜라노마 세포(B-16 마우스 멜라노마 세포)의 배양액에 첨가하여 세포수준에서의 미백효과를 실험하였다(Lotan R., Lotan D. Cancer Res. 40:3345-3350, 1980).The whitening effect at the cellular level was examined by adding galloyl quinic acid isolated in the above preparation to the culture of rat melanoma cells (B-16 mouse melanoma cells) (Lotan R., Lotan D. Cancer Res). 40: 3345-3350, 1980).
갈로일 퀴닉산을 B-16 멜라노마 세포의 배양시 배지에 첨가하여 3일간 배양한 후 세포들을 트립신처리하여 배양 용기로부터 떼어내 원심분리한 후 멜라닌을 추출해 낸다. 이것에 수산화 나트륨 용액(1N 농도) 1㎖를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용, 400 나노미터에서 흡광도를 측정하여 생성된 멜라닌의 양을 단위 세포 수당(106cell)의 흡광도로 나타내는 방법으로 수행하였다. 그 결과는 하기 표 2 에 나타내었다.Galoyl quinic acid is added to the culture medium of B-16 melanoma cells and cultured for 3 days, and then cells are trypsinized, separated from the culture vessel, centrifuged, and melanin is extracted. To this, 1 ml of sodium hydroxide solution (1N concentration) was added, boiled for 10 minutes to dissolve the melanin, and the absorbance was measured at 400 nanometers using a spectrophotometer indicating the amount of melanin produced as the absorbance of a unit cell allowance (10 6 cells). It was performed by the method. The results are shown in Table 2 below.
[표 2]TABLE 2
갈로일 퀴닉산의 B-16 멜라노마 세포에 대한 멜라닌 생성 억제효과Inhibitory Effect of Galoyl Quinic Acid on Melonogenesis in B-16 Melanoma Cells
*반복수 = 3* Repeat count = 3
상기 표 2 의 결과로부터, 갈로일 퀴닉산에는 강력하고 우수한 멜라닌 생성억제능이 있음을 알 수 있다. 이것은 본 발명의 피부미백용 조성물이 기미나 주근깨 개선 또는 피부미백에 매우 유용하게 사용될 수 있음을 입증한다.From the results of Table 2, it can be seen that galloyl quinic acid has strong and excellent melanin production inhibitory ability. This demonstrates that the composition for skin whitening of the present invention can be very usefully used for improving skin or freckles or skin whitening.
이와 같이 멜라닌 생성억제 효과가 우수한 갈로일 퀴닉산을 가지고 다음과 같은 조성성분 및 조성비에 따라 실시예 1 내지 5의 피부미백용 조성물을 제조하였다.Thus, the composition for skin whitening of Examples 1 to 5 was prepared according to the following composition ingredients and composition ratios with galloyl quinic acid having an excellent melanin production inhibitory effect.
[실시예 1]Example 1
[실시예 2]Example 2
[실시예 3]Example 3
[실시예 4]Example 4
[실시예 5]Example 5
[실험예 3]Experimental Example 3
건강한 남자 20명의 실험대상자의 한쪽팔 상박부에 2cm × 2cm의 크기로 3개씩 2줄의 구멍이 뚫린 알루미늄 호일로 덮은 후 일광조사기(ORIEL Solar Simulator 1000W)를 이용 50cm거리에서 120mJ/㎠의 광량을 조사하였다. 조사전 에탄올 70% 수용액으로 조사부위를 잘 세척하였다. 자외선 조사후 조사부위 한쪽줄 3곳에는 실시예 1, 3 및 5를, 다른 한 줄에는 각각의 기제를 1일 2회, 4주간 도포하였다. 4주 후에는 육안으로 색소침착의 정도를 대조군(기제도포)과 비교하여 판정하였으며, 판정 기준은 현저한 저해효과, 약간의 저해효과, 저해효과 없음의 3단계 평가로 하였다. 그 결과는 다음 표 3 에 나타내었다.20 healthy male subjects were covered with aluminum foil with two perforated lines of 2cm x 2cm in the upper arm of each arm, and 120mJ / ㎠ light at 50cm distance using a ORIEL Solar Simulator 1000W. Investigate. The irradiation site was washed well with 70% aqueous ethanol solution before irradiation. After UV irradiation, Examples 1, 3, and 5 were applied to one row of three irradiation sites, and each base was applied twice a day for four weeks to the other row. Four weeks later, the degree of pigmentation was visually determined by comparison with the control group (gigi coating), and the criterion was a three-step evaluation of remarkable inhibitory effect, slight inhibitory effect, and no inhibitory effect. The results are shown in Table 3 below.
[표 3]TABLE 3
색소침착 저해효과(명)Pigmentation inhibitory effect (persons)
상기 표 3 의 결과로부터 알 수 있듯이 본 발명에 의한 실시예 1, 3 및 5는 모두 최소 14 명 이상이 약간의 색소침착저해 이상의 효과를 나타냄으로 본 발명에 의한 피부미백용 조성물이 매우 우수한 색소침착 저해효과가 있음을 입증한다.As can be seen from the results of Table 3, Examples 1, 3 and 5 according to the present invention are all at least 14 people at least a slight pigmentation inhibitory effect is more excellent pigmentation composition for skin whitening according to the present invention Demonstrates an inhibitory effect.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960052295A KR19980034292A (en) | 1996-11-06 | 1996-11-06 | Skin whitening composition containing galloylquinic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960052295A KR19980034292A (en) | 1996-11-06 | 1996-11-06 | Skin whitening composition containing galloylquinic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
KR19980034292A true KR19980034292A (en) | 1998-08-05 |
Family
ID=66519965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960052295A KR19980034292A (en) | 1996-11-06 | 1996-11-06 | Skin whitening composition containing galloylquinic acid |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR19980034292A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030037993A (en) * | 2001-11-08 | 2003-05-16 | 주식회사 엘지생활건강 | Composition for skin whitening containing 1-desgalloyleugeniin |
US9233263B2 (en) | 2004-04-01 | 2016-01-12 | Industrial Farmaceutica Cantabria, S.A. | Photoprotector and/or photoimmunoprotector compositions of the skin and their uses |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6064947A (en) * | 1984-07-31 | 1985-04-13 | Nippon Shinyaku Co Ltd | Tannin |
JPH03178916A (en) * | 1989-12-06 | 1991-08-02 | Shiseido Co Ltd | Skin external agent |
JPH03258711A (en) * | 1990-03-06 | 1991-11-19 | Sansho Seiyaku Co Ltd | Skin-whitening agent for external use |
JPH06183989A (en) * | 1992-08-03 | 1994-07-05 | Soc Prod Nestle Sa | Antiurease cosmetics or dermatologic composition |
JPH0892053A (en) * | 1994-09-20 | 1996-04-09 | Tsuneo Nanba | External preparation for skin |
KR970007186A (en) * | 1995-07-31 | 1997-02-21 | 배순훈 | Refrigerant control device using dual evaporator of refrigerator |
-
1996
- 1996-11-06 KR KR1019960052295A patent/KR19980034292A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6064947A (en) * | 1984-07-31 | 1985-04-13 | Nippon Shinyaku Co Ltd | Tannin |
JPH03178916A (en) * | 1989-12-06 | 1991-08-02 | Shiseido Co Ltd | Skin external agent |
JPH03258711A (en) * | 1990-03-06 | 1991-11-19 | Sansho Seiyaku Co Ltd | Skin-whitening agent for external use |
JPH06183989A (en) * | 1992-08-03 | 1994-07-05 | Soc Prod Nestle Sa | Antiurease cosmetics or dermatologic composition |
JPH0892053A (en) * | 1994-09-20 | 1996-04-09 | Tsuneo Nanba | External preparation for skin |
KR970007186A (en) * | 1995-07-31 | 1997-02-21 | 배순훈 | Refrigerant control device using dual evaporator of refrigerator |
Non-Patent Citations (1)
Title |
---|
붉은대극의 페놀성화합물, 안병태, 이경순, 생약학회지, 1996, pp.136~141 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030037993A (en) * | 2001-11-08 | 2003-05-16 | 주식회사 엘지생활건강 | Composition for skin whitening containing 1-desgalloyleugeniin |
US9233263B2 (en) | 2004-04-01 | 2016-01-12 | Industrial Farmaceutica Cantabria, S.A. | Photoprotector and/or photoimmunoprotector compositions of the skin and their uses |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100816314B1 (en) | Skin texture-improving agents | |
KR19980042150A (en) | Use of Sericin as an Antioxidant or Tyrosinase Inhibitor | |
KR20080001791A (en) | Skin anti-wrinkle cosmetics composition containing forsythiae fruit extract | |
JP4831849B2 (en) | Active oxygen scavenger and its use | |
KR100190993B1 (en) | Water soluble fraction extracts of asparagus cochinchinensis having improved skin whitening defects by removing darkening components and a composition for improving freckles and skin whitening containing thereof | |
KR100190992B1 (en) | A skin whitening composition containing extracts of asparagus cochinchinensis and tyrosinase inhibitor | |
KR100466379B1 (en) | Composition for skin whitening | |
KR100496850B1 (en) | The Skin Lightening Cosmetic Composition Containing Extract Of Gardenia | |
KR19980050697A (en) | Green mushroom extract and skin cosmetic containing same | |
JPH0987164A (en) | Skin preparation for external use | |
KR20190081627A (en) | Cosmetic composition for whitening and anti-wrinkle containing Batillus cornutus derived peptide powder | |
KR19980034292A (en) | Skin whitening composition containing galloylquinic acid | |
KR20090117364A (en) | Cosmetic composition for whitening of the skin comprising the extract of brucea javanica as active ingredient | |
KR100416400B1 (en) | Composition containing extracts from dried roots of Trichosantes kirilowii maxim for external application and skin-whitening and process for preparation thereof | |
JP2001507009A (en) | Use of Cordia dicotoma extract | |
KR19980034291A (en) | Skin whitening composition containing galloylgalactose | |
KR19990081226A (en) | Skin cosmetic using natural mushrooms | |
KR100453217B1 (en) | Skin whitener | |
KR19980034290A (en) | Skin whitening composition containing gallic acid derivative | |
KR19980034293A (en) | Skin whitening composition containing galloyl simic acid | |
KR19980027092A (en) | Skin whitening composition containing antibacterial plant extract | |
KR100190989B1 (en) | Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof | |
KR19980034289A (en) | Skin whitening composition containing galloyl allose | |
KR100604085B1 (en) | Cosmetics containing Ramulus mori extracts and glutathione for skin whitening | |
KR100629065B1 (en) | Cosmetic compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |